A study was undertaken to examine trends in the incidence and mortality of myocardial infarction in Sweden. All cases (n= 19 908) of myocardial infarction diagnosed in the population of Stockholm county during 1974-80 were identified by means of the cause of death register and the inpatient care register. Information on patients at risk was obtained from the civil registration system. The relative risk of developing, or dying of, myocardial infarction in one specific year, compared with the average for the whole period, was taken as the basis for describing the trends. For men in Stockholm the incidence as well as the mortality was appreciably increased; the annual increase in incidence was 3% and in mortality 4%. There were no signs of decreasing lethality. For women there was an appreciable increase in incidence; for mortality the result was less specific but was compatible with an increase. The observed increases in incidence and mortality appeared to be real and were probably not due to an increasing tendency for patients to seek hospital treatment or for doctors to make the diagnosis. The reason for the increase is unknown.
Introduction
Mortality from ischaemic heart disease has declined since the mid 1960s in the United States and several other industrialised countries.'-3 It is still unclear whether the decline in ischaemic heart disease stems from declining incidence or from declining lethality. 4 In Sweden the morbiditv as well as the mortality from this disease are low compared with many other countries, including the United States.5 6 The aim of the present study was to examine the trends in incidence of as well as in mortality from acute myocardial infarction in Stockholm county for the years 1974-80.
Patients and methods
Sweden has a highly efficient civil registration system. On the basis of this system the national cause of death register and the medical information systems in the county councils, which contain comprehensive inpatient care The likelihood ratio test showed that the relative risk differed significantly between the years (p =2 x 10 9). Fig 1 also shows the regression line fitted to the relative risks. The slope of the line indicates that the incidence of myocardial infarction increased by about 3"0 per year.
Fig 2 shows the corresponding relative risks of women. These data also show a significant difference between the years and a clear increase in the relative risks during the period.
Figs 3 and 4 show the mortality data for men and women respectively. For men a significant difference in mortality from myocardial infarction was observed. According to the slope of the regression line the increase was about 4o0 a year. For women the mortality did not differ significantly between the years, even though the regression line showed a moderate increase.
Discussion
The results of this study of myocardial infarction in Stockholm county during the years 1974-80 indicate that for men there were definite increases in both incidence and mortality. For women there was a definite increase in incidence; for mortality the result was less specific but was compatible with an increase. This study used data obtained from the national register of deaths and from a medical information system. The validity of this information together with the methodology for using it for epidemiological purposes has been described.8 " In general this information was found to be as accurate as that obtained from special registers of myocardial infarction. Despite this one explanation of the observed trend may have been an increased tendency of doctors during the period to make the diagnosis of myocardial infarction or an increased tendency of patients to seek medical care for symptoms that may have been due to a myocardial infarction.'2 If so, an increase in the proportion of less severe cases would have been expected. Since the mortality increased as much as the incidence, however, this seems to be a less likely explanation. Furthermore, a decrease in lethality might also have been expected. A scrutiny of case fatality rates, however, showed no such decrease.
The increases in incidence and mortality rates appeared to be real and were probably not due to an increasing tendency to seek hospital treatment or to make the diagnosis. The reason for the increase remains unknown. As regards treatment, the proportion of patients with treated and well controlled hypertension seems to have risen.'3 Nevertheless, we do not know whether the prevalence of hypertension increased during the period. The use of beta-blockers increased considerably during the period. The effect of this on morbidity and mortality from myocardial infarction is, however, low.'3 14 The effect of coronary bypass operations on the disease is probably negligible.'3 It is also probable that the improvement, if any, in mortality rates due to the introduction of coronary care units occurred mainly before the period studied.
As regards risk indicators, a favourable trend is reflected in the decline in the proportion of smokers in the Swedish population during the period according to surveys carried out by the National Smoking and Health Association. An unfavourable trend, however, is the increase in the proportion of fat in the diet of the population during the past four decades at least according to official statistics. In Sweden the years 1974-80 were characterised by social and economic instability which was unknown to Swedes, who are accustomed to the idea of almost total social security. According to Brenner socioeconomic factors contributed to changes in mortality from coronary heart disease.'15 Possible neuroendocrine mechanisms underlying these associations are, however, largely unknown. Further research is needed into the trends of known risk factors of cardiovascular disease. There is also concern regarding the psychological effects of early diagnosis. We asked parents of boys with the disease whether they were in favour of screening for the disease and, if they were, when they thought it should be carried out.
Methods and results
We interviewed 69 parents from 53 families of boys suffering from Duchenne muscular dystrophy to explore their views of neonatal screening, services, and their experiences at the time of diagnosis.2 All parents were asked their opinions on the desirability of screening for the disease and, if they were in favour of screening, whether it should be carried out close to birth, at 18 months, or at some other time.
In 75% of the families (90%, of those who expressed an opinion) the parents were in favour of neonatal screening. This finding is similar to the findings of Beckmann and Scheuerbrandt.3 Of the four parents who thought that screening should take place at some other time, three said it should be carried out at between 1 and 3 months. Three parents thought that in their case earlier diagnosis would have been undesirable.
Parents were also asked the reasons for their views. Five major reasons were given by those who stated a preference for neonatal screening: (1) it prevented parents experiencing the negative effects of long delays between the first symptoms and diagnosis that are associated with the present diagnostic system; (2) parents had a "right" to be informed as soon as scientifically possible; (3) it prevented the birth of further affected sufferers of the disease to carrier mothers and their female relatives; (4) it had practical advantages-for example, the opportunity to buy or rent appropriate housing; and (5) it had emotional advantages.
Comment
No control group was used in this study, and the views of the parents on the advantages and disadvantages of neonatal screening were not based on any experience of such screening. The parents had, however, experienced a diagnostic system that many had found unsatisfactory.
Two major ethical objections to neonatal screening have been raised: firstly, there is no treatment that will benefit the patient; and, secondly, diagnosis might have psychological effects, including rejection or overprotection of the child. Although no cure exists, there is an argument that with a disease as devastating as Duchenne muscular dystrophy "the family is the patient."4 The potential benefits of neonatal screening to families include early support and genetic counselling. Two important influences on how parents react to the diagnosis of a serious disease are the way in which they are told of the diagnosis and how they are supported subsequently. Our study disclosed dissatisfaction with both these points.5 Our findings mirror those of studies of other handicapping conditions, which
